At Asembia AXS26, Dee Chaudhary broke down how shifting US drug pricing policy is tightening payer controls and changing ...

Scaling from ultra-rare volumes to mainstream indications threatens redundancy-heavy manufacturing and logistics, forcing ...

Live from Asembia AXS26, Jessica Lovett explains what real world evidence and data matters most in making decisions around ...

PBM reform is accelerating via FTC settlements and CAA 2026, mandating data reporting, rebate pass-through in Part D, ...

Joel Wayment discusses the implications of the growing cell and gene therapy market on pharma supply chains. The rise in cell ...

Following his keynote address at LogiPharma Europe 2026, Nico Vandaele, professor of Operations Research & Operations ...

Nico Vandaele shares how advanced modeling and simulations can be used to get ahead of future supply chain disruptions.

Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...

Pharmaceutical cold chain logistics is entering a phase where data quality and decision speed matter as much as physical ...

Raquel Vazquez discusses how data can be incorporated to make key decisions within the cold chain.

Rahul Shah and Mack MacKenzie explain how to unlock the ROI that rules-based systems have left on the table.

In the following Q&A, Shawn McGee, VP of National Accounts at A. Duie Pyle, shares insights on today’s key risks, including ...